In vitro glucocorticoid sensitivity is associated with clinical glucocorticoid therapy outcome in rheumatoid arthritis. 2012

Rogier A M Quax, and Jan W Koper, and Pascal H P de Jong, and Ramona van Heerebeek, and Angelique E Weel, and Anne M Huisman, and Derkjen van Zeben, and Frank H de Jong, and Steven W J Lamberts, and Johanna M W Hazes, and Richard A Feelders

BACKGROUND Genetic and disease-related factors give rise to a wide spectrum of glucocorticoid (GC) sensitivity in rheumatoid arthritis (RA). In clinical practice, GC treatment is not adapted to these differences in GC sensitivity. In vitro assessment of GC sensitivity before the start of therapy could allow more individualized GC therapy. The aim of the study was to investigate the association between in vitro and in vivo GC sensitivity in RA. METHODS Thirty-eight early and 37 established RA patients were prospectively studied. In vitro GC sensitivity was assessed with dexamethasone-induced effects on interleukin-2 (IL-2) and glucocorticoid-induced leucine zipper (GILZ) messenger RNA expression in peripheral blood mononuclear cells (PBMCs). A whole-cell dexamethasone-binding assay was used to measure number and affinity (1/KD) of glucocorticoid receptors (GRs). RESULTS GR number was positively correlated with improvement in DAS. IL-2-EC₅₀ and GILZ-EC₅₀ values both had weak near-significant correlations with clinical improvement in DAS in intramuscularly treated patients only. HAQ responders had lower GILZ-EC₅₀ values and higher GR number and KD. CONCLUSIONS Baseline cellular in vitro glucocorticoid sensitivity is modestly associated with in vivo improvement in DAS and HAQ-DI score after GC bridging therapy in RA. Further studies are needed to evaluate whether in vitro GC sensitivity may support the development of tailor-made GC therapy in RA.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008297 Male Males
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

Rogier A M Quax, and Jan W Koper, and Pascal H P de Jong, and Ramona van Heerebeek, and Angelique E Weel, and Anne M Huisman, and Derkjen van Zeben, and Frank H de Jong, and Steven W J Lamberts, and Johanna M W Hazes, and Richard A Feelders
January 2010, Arthritis research & therapy,
Rogier A M Quax, and Jan W Koper, and Pascal H P de Jong, and Ramona van Heerebeek, and Angelique E Weel, and Anne M Huisman, and Derkjen van Zeben, and Frank H de Jong, and Steven W J Lamberts, and Johanna M W Hazes, and Richard A Feelders
February 2002, Annales de medecine interne,
Rogier A M Quax, and Jan W Koper, and Pascal H P de Jong, and Ramona van Heerebeek, and Angelique E Weel, and Anne M Huisman, and Derkjen van Zeben, and Frank H de Jong, and Steven W J Lamberts, and Johanna M W Hazes, and Richard A Feelders
October 2016, Deutsche medizinische Wochenschrift (1946),
Rogier A M Quax, and Jan W Koper, and Pascal H P de Jong, and Ramona van Heerebeek, and Angelique E Weel, and Anne M Huisman, and Derkjen van Zeben, and Frank H de Jong, and Steven W J Lamberts, and Johanna M W Hazes, and Richard A Feelders
November 2000, Rheumatic diseases clinics of North America,
Rogier A M Quax, and Jan W Koper, and Pascal H P de Jong, and Ramona van Heerebeek, and Angelique E Weel, and Anne M Huisman, and Derkjen van Zeben, and Frank H de Jong, and Steven W J Lamberts, and Johanna M W Hazes, and Richard A Feelders
October 2016, Deutsche medizinische Wochenschrift (1946),
Rogier A M Quax, and Jan W Koper, and Pascal H P de Jong, and Ramona van Heerebeek, and Angelique E Weel, and Anne M Huisman, and Derkjen van Zeben, and Frank H de Jong, and Steven W J Lamberts, and Johanna M W Hazes, and Richard A Feelders
July 2018, Joint bone spine,
Rogier A M Quax, and Jan W Koper, and Pascal H P de Jong, and Ramona van Heerebeek, and Angelique E Weel, and Anne M Huisman, and Derkjen van Zeben, and Frank H de Jong, and Steven W J Lamberts, and Johanna M W Hazes, and Richard A Feelders
June 2012, Rheumatology (Oxford, England),
Rogier A M Quax, and Jan W Koper, and Pascal H P de Jong, and Ramona van Heerebeek, and Angelique E Weel, and Anne M Huisman, and Derkjen van Zeben, and Frank H de Jong, and Steven W J Lamberts, and Johanna M W Hazes, and Richard A Feelders
November 1995, Revue du rhumatisme (English ed.),
Rogier A M Quax, and Jan W Koper, and Pascal H P de Jong, and Ramona van Heerebeek, and Angelique E Weel, and Anne M Huisman, and Derkjen van Zeben, and Frank H de Jong, and Steven W J Lamberts, and Johanna M W Hazes, and Richard A Feelders
November 2018, Clinical and experimental immunology,
Rogier A M Quax, and Jan W Koper, and Pascal H P de Jong, and Ramona van Heerebeek, and Angelique E Weel, and Anne M Huisman, and Derkjen van Zeben, and Frank H de Jong, and Steven W J Lamberts, and Johanna M W Hazes, and Richard A Feelders
March 1993, The Journal of rheumatology,
Copied contents to your clipboard!